Mycoplasma Genitalium (MG) Infections in Canadian Women with Chlamydia Trachomatis (CT) and/or Neisseria Gonorrhoeae (NG)
Max Chernesky, PhD1, Dan Jang, BSc2, Jodi Gilchrist, BSc, MSc1, Linda Hoang, MD3, Prenilla Naidu, MD, FRCPC4, Paul Levett, PHD5, John Wylie, PhD6, Anu Rebbapragada, PhD7, Todd Hatchette, MD8, Ameeta Singh, BMBS, MSc, FRCPC9, Ron Read, MD/PhD10, Petra Smyczek, MD PhD FRCPC11, Sam Ratnam, PhD12, Paul Vancaeseele, MD13, Annie-Claude Labbe, MD14, Damon Getman, PhD15, Marek Smieja, MD, PhD1 and Irene Martin, BSC16, 1St. Joseph's Healthcare/McMaster University, Hamilton, ON, Canada, 2Research, St. Joseph's Healthcare/McMaster University, Hamilton, ON, Canada, 3British Columbia Centre for Disease Control, Vancouver, BC, Canada, 4Bacteriology, Provincial Laboratory for Public Health, Alberta Health Services, Edmonton, AB, Canada, 5Saskatchewan Disease Control Laboratory, 6Cadham Provincial Laboratory, University of Manitoba, Winnipeg, MB, Canada, 7Dynacare, Brampton, ON, Canada, 8Dalhousie University, Halifax, NS, Canada, 9Division of Infectious Diseases, University of Alberta, Edmonton, AB, Canada, 10Alberta Health Services, Edmonton, AB, Canada, 11STI Services, Alberta Health Services, Edmonton, AB, Canada, 12Public Health Laboratory, Eastern Health, St. John's, NF, Canada, 13Cadham Provincial Laboratory, Winnipeg, MB, Canada, 14University of Montreal, Montreal, QC, Canada, 15Research and Development, Women's Health Diagnostics, Hologic Inc, San Diego, CA, 16National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada